Pharmabiz37m
Bayer announces positive results of pivotal phase III QUANTI studies of gadoquatrane, an investigational GBCA for use in magnetic resonance imaging
Bayer announces positive results of pivotal phase III QUANTI studies of gadoquatrane, an investigational GBCA for use in magnetic resonance imaging: Berlin Monday, January 13, 202 ...
Pharmabiz2h
ASPA to host 6th edition of Traceability and Authentication Forum 2025 on March 17 & 18 at New Delhi
ASPA to host 6th edition of Traceability and Authentication Forum 2025 on March 17 & 18 at New Delhi: Our Bureau, Bengaluru Monday, January 13, 2025, 09:00 Hrs [IST] The Authentic ...
Pharmabiz1h
New European Union rules for health technology assessments become effective
New European Union rules for health technology assessments become effective: Amsterdam, The Netherlands Monday, January 13, 2025, 10:00 Hrs [IST] EMA is ready to support the imple ...
Pharmabiz3h
Molbio Diagnostics redefines molecular diagnostics with Truenat
Molbio Diagnostics redefines molecular diagnostics with Truenat: Monday, January 13, 2025, 08:00 Hrs [IST] In a world marked by significant healthcare disparities and the rising b ...
Pharmabiz3h
KPRDO asks FDA to take action against Swiggy & PharmEasy for drug delivery in 10 minutes
KPRDO asks FDA to take action against Swiggy & PharmEasy for drug delivery in 10 minutes: Nandita Vijayasimha, Bengaluru ...
Pharmabiz3h
Allowing separate timelines for large units and MSMES may create two categories of manufacturing facilities: Experts
Gireesh Babu, New Delhi Monday, January 13, 2025, 08:00 Hrs [IST] ...
Pharmabiz3h
MP DCA forms team of regulatory officers to assist pharma units in upgrading plants as per revised Schedule M
Peethaambaran Kunnathoor, Chennai Monday, January 13, 2025, 08:00 Hrs [IST] ...
Pharmabiz3h
Panel asks govt to provide duty concessions, reduced GST rates for growth of medical devices manufacturing
Panel asks govt to provide duty concessions, reduced GST rates for growth of medical devices manufacturing: Gireesh Babu, New Delhi Monday, January 13, 2025, 08:00 Hrs [IST] A Par ...
Pharmabiz3h
Exporters concerned over delay in getting relief under Section 43B(h) of IT Act
Exporters concerned over delay in getting relief under Section 43B(h) of IT Act: Shardul Nautiyal, Mumbai Monday, January 13, 2025, 08:00 Hrs [IST] India’s pharmaceutical export ...
Pharmabiz5d
JCR Pharma & Modalis validate initial proof of concept in a joint research programme for development of a novel gene therapy for a CNS disease
JCR Pharmaceuticals Co., Ltd., a global specialty pharmaceuticals company, and Modalis Therapeutics Corporation, a forerunner in the field of epigenetic medicine, announced that they have validated ...
Pharmabiz5d
US FDA grants orphan drug designation to NMD Pharma’s NMD670 to treat patients with Charcot-Marie-tooth disease
NMD Pharma A/S, a clinical-stage biotech company dedicated to developing novel and improved treatments for patients living with neuromuscular diseases, announces that the US Food and Drug ...
Pharmabiz6d
Eton Pharma acquires Galzin, an US FDA approved treatment of ultra-rare metabolic condition of Wilson disease
Eton Pharmaceuticals, Inc, an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, announced that it has acquired Galzin (zinc acetate). “This ...